# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-16-092307
Filing Date
2016-04-01
Accepted
2016-04-01 16:17:26
Documents
10
Period of Report
2016-04-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | v435857_8k.htm | 8-K | 19238
2 | EXHIBIT 99.1 | v435857_ex99-1.htm | EX-99.1 | 8925
3 | EXHIBIT 99.2 | v435857_ex99-2.htm | EX-99.2 | 8716
4 | EXHIBIT 99.3 | v435857_ex99-3.htm | EX-99.3 | 7862
5 | EXHIBIT 99.4 | v435857_ex99-4.htm | EX-99.4 | 6853
6 | GRAPHIC | image_001.jpg | GRAPHIC | 17241
7 | GRAPHIC | ex99x1_001.jpg | GRAPHIC | 154510
8 | GRAPHIC | ex99x2_001.jpg | GRAPHIC | 148171
9 | GRAPHIC | ex99x3_001.jpg | GRAPHIC | 157501
10 | GRAPHIC | ex99x4_001.jpg | GRAPHIC | 141531
| Complete submission text file | 0001144204-16-092307.txt |  | 906023

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 161547353
SIC: 2834 Pharmaceutical Preparations